(Reuters) - Roche said in a statement on Friday that it had received a positive opinion for Mircera from the European Committee for Medicinal Products for Human Use -- whose recommendations are normally formally endorsed by European regulators within a couple of months.
The recommendation is good news for Roche after Mircera suffered a delay in the U.S. approval process.
Read more at Reuters.com Government Filings News
The recommendation is good news for Roche after Mircera suffered a delay in the U.S. approval process.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment